Allscripts (MDRX) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- Equities turn higher as Treasury yields drop from highs
- Fed’s Jefferson sees no urgency for another rate increase
- Oil prices rise $3 after China suspends fuel exports
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Anthropic targets mid-November for public debut - report
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- Micron Technology (MU) Tops Q4 EPS by $2.26, Offers Guidance
Allscripts Announces Third Quarter 2020 Results
October 29, 2020 4:01 PM EDTThird quarter operating margin and Adjusted EBITDA margin increased both year-over-year and sequentially GAAP EPS of $0.00; 18% year-over-year growth in non-GAAP diluted EPS to $0.20 Generated $53 million of operating cash flow and $27 million of free cash flow in the third quarter
CHICAGO--(BUSINESS WIRE)-- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and nine months ended September 30, 2020.
Bookings(1) were $187 million in the third quarter of 2020. This result compares with $236 million in the third quarter of 2019. Contract revenue... More
